STERIS plc (STE) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2026, STERIS reported revenue of $5.94B, up 8.7% from $5.46B the year before. Net income was $782.3M (a 13.2% net margin), or $7.93 per diluted share. Gross margin was 44.2% and operating margin was 18.6%. Operating activities generated $1.34B of cash, leaving $972.4M of free cash flow. At fiscal year end, STERIS held $10.74B in total assets against $3.54B in total liabilities.
Open the full interactive STERIS financials → Quarterly statements, key ratios, valuation history and price charts.
STERIS Key Stats
| Share Price | $217.77 |
|---|---|
| Market Cap | $21.32B |
| P/E Ratio | 27.5 |
| Revenue YoY Growth | +8.7% |
| 52-Week Range | $198.79 – $266.36 |
| Shares Outstanding | 97.6 million (basic, 2027 Q1) |
STERIS Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $3.11B | $4.59B | $4.96B | $5.14B | $5.46B | $5.94B |
| Cost of Goods Sold | $1.76B | $2.57B | $2.80B | $2.92B | $3.06B | $3.31B |
| Gross Profit | $1.34B | $2.02B | $2.16B | $2.22B | $2.40B | $2.63B |
| Operating Income | $548.4M | $425.6M | $268.2M | $836.1M | $866.6M | $1.10B |
| Pre-Tax Income | $517.5M | $314.5M | $157.3M | $702.8M | $796.2M | $1.05B |
| Income Tax | $120.7M | $71.6M | $51.5M | $149.5M | $184.7M | $262.2M |
| Net Income | $397.4M | $243.9M | $107.0M | $378.2M | $614.6M | $782.3M |
| Diluted EPS | $4.63 | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
STERIS Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.59B | $1.49B |
| Net Income | $191.9M | $192.9M | $220.1M | $200.1M |
| Diluted EPS | $1.94 | $1.96 | $2.23 | $2.04 |
STERIS Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $220.5M | — | — | — | — | — |
| Current Assets | $1.21B | $1.88B | $2.01B | $2.87B | $2.00B | $2.39B |
| Total Assets | $6.57B | $11.42B | $10.82B | $11.06B | $10.15B | $10.74B |
| Current Liabilities | $577.9M | $922.2M | $861.8M | $931.1M | $1.02B | $1.15B |
| Total Long-Term Debt | $1.65B | $2.95B | $3.02B | $3.12B | $1.92B | $1.81B |
| Total Liabilities | $2.68B | $4.88B | $4.73B | $4.75B | $3.53B | $3.54B |
| Shareholders' Equity | $3.88B | $6.53B | $6.08B | $6.30B | $6.60B | $7.18B |
STERIS Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $689.6M | $684.8M | $756.9M | $973.3M | $1.15B | $1.34B |
| Cash From Investing | -$1.15B | -$666.6M | -$383.3M | -$887.4M | $388.8M | -$512.5M |
| Cash From Financing | $345.6M | $115.8M | -$498.7M | -$85.2M | -$1.57B | -$568.2M |
| Free Cash Flow | $450.4M | $397.2M | $395.0M | $612.9M | $778.0M | $972.4M |
Figures from STERIS's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full STERIS financials page for every line item.
STERIS Company Profile
| Ticker | STE |
|---|---|
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Dublin, Ireland |
| Fiscal Year End | March 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001757898 |
Frequently Asked Questions
What was STERIS's revenue in fiscal 2026?
STERIS (STE) reported revenue of $5.94B for fiscal 2026.
What is STERIS's annual revenue history?
STERIS's annual revenue by fiscal year: 2021: $3.11B; 2022: $4.59B; 2023: $4.96B; 2024: $5.14B; 2025: $5.46B; 2026: $5.94B.
What was STERIS's net income in fiscal 2026?
STERIS reported net income of $782.3M for fiscal 2026.
What was STERIS's earnings per share (EPS) in fiscal 2026?
STERIS's diluted EPS was $7.93 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did STERIS generate in fiscal 2026?
STERIS generated $972.4M of free cash flow in fiscal 2026.
What was STERIS's revenue last quarter?
In its most recent reported quarter (2027 Q1), STERIS reported revenue of $1.49B.
How much debt does STERIS have?
STERIS reported $1.81B of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of STERIS are outstanding?
STERIS reported a weighted average of 97.6 million basic shares outstanding in 2027 Q1.
What is STERIS's market cap?
Based on its latest closing price, STERIS (STE) has a market capitalization of about $21.32B.
When does STERIS's fiscal year end?
STERIS's fiscal year end, as registered with the SEC, is March 31.
Where is STERIS headquartered?
STERIS lists its business address in Dublin, Ireland in its SEC filings.
STERIS Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →